CANCER'S CAUSE, CANCER'S CURE (3 page)

When I started my research on Mirko Beljanski, Ph.D., I was determined that I would use his findings as a way to warn my readers away from conventionally administered cancer therapies. Radiation treatment assuredly burns any tissues it touches, and chemicals given as cancer therapy produce adverse side effects of one’s metabolism so awful, they often cause the patient eventually to wish for death. I have long advocated for my readers to avoid them because nearly all of their applications are deadly, damaging, and costly; plus they deteriorate the quality of life for someone who is already at death’s door.

I am a doctor of podiatric medicine (D.P.M.), but as a full-time medical journalist for the past forty-plus years, my advice is, and has always been, to seek the services of a holistic-oriented health-care professional such as a naturopath, a homeopath, an acupuncturist, or an herbalist who keeps you out of the hospital or who uses very few pharmaceutical products or no drugs at all.

I have especially been outspoken against the pharmaceutical industry, the companies who make the drugs as well as their powerful lobbyists. I stand firm with Dr. Julian Whitaker, who in his March 2011 “
Health & Healing
¨ monthly newsletter, wrote: “The pharmaceutical industry makes the most dangerous products on the planet. Prescription meds are our fourth leading cause of death, and some of them have unthinkable side effects. Psychiatric drugs, for instance, have been linked to countless suicides, school shootings, and other bizarre acts of violence such as mothers killing their own children.

“The large drug companies are cash cows. According to Fortune 500 rankings, their mean profit margin is 20 percent, compared to an 8 percent average across all industries… Big Pharma gets irrational sweetheart deals from the government. For Medicare prescription drug coverage, prices are not negotiable. They [Big Pharma] can charge the government whatever they want!

“This industry spends nearly twice as much on advertising as they do on research and development. Direct-to-consumer advertising, which is allowed only in the U.S. and New Zealand, has created unprecedented demand for medications, driven up usage and profits, and corrupted the doctor-patient relationship.”

You can verify Dr. Julian Whitaker’s statements by just turning on your television set. Over half of the ads on television it seems are for one kind of drug or another. It makes you wonder why the drug companies need to promote their drugs so heavily.

While cancer drugs are not advertised, it is an irrefutable fact that chemotherapy and radiation currently being prescribed by oncologists world-wide are unable to effectively distinguish between cells to be destroyed and cells to be preserved. For this reason at the present time, a “cure” for cancer does not exist and frequently the establishment’s treatment is as deadly as the disease.

But this is what makes Dr. Beljanski’s approach so important. You can imagine my surprise when I learned that Dr. Beljanski’s supplements, while amazingly effective on their own, when coupled with
low
doses of radiation and chemotherapy, are effective,
perhaps more so than any other combined treatment available.

I was astounded.

I am holistic to the core of my being, but Beljanski was a meticulous researcher, constantly probing the depths of what was known and unknown about cancer at the cellular level. His discoveries work because they are selective against a collection of cellular deviations identified as a
malignancy,
a
mass,
a
tumor,
a
growth,
or a
cancer.
In the course of destroying the illness, Beljanski’s botanicals target the cancerous cells. Not only do they suppress or destroy cancer cells, but they also distinguish harmful cells from healthy ones and thereby leave healthy cells undamaged. His approach is different from anything offered by modern oncology.

Mirko Beljanski’s research took him to the very core of our physical life—to the basic building blocks of DNA and its close kin, RNA. He discovered what happens to the DNA of a cancer cell and how that can be rectified to bring about that all important balance in the human cell. His research into RNA was revolutionary at a time when RNA was relegated to the back burners of most laboratories, including the Pasteur; it yielded results that in our modern day of incurable diseases are indispensable.

This is a highly important subject—vital for the saving of lives— and I consider myself privileged to bring it to you. Beljanski’s anticancer approach is scientifically based, tested, and proven both in the laboratory and in human clinical trials. If indeed we are at war against cancer and not against each other, if we are truly going to best this scourge that according to most accounts is worsening across the globe, then it is time to put aside our differences, look at the evidence at hand, and soldier ahead. For we
can
win this war on cancer if we let the discoveries of Dr. Mirko Beljanski lead the way.

Introduction

I
n the spring of 1992, Jean-Paul Le Perlier, a French journalist known for his forthright news editorials in political journals and newspapers along with five national bestselling books, was contacted by his closest friend. This friend also just happened to be a major figure in the world of the international pharmaceutical companies. The drug-company executive asked Monsieur Le Perlier if he would investigate one Dr. Mirko Beljanski. Why? Because his drug company’s sales were being adversely affected by certain products Beljanski created. This friend claimed the microbiologist was a “quack” and wanted Le Perlier to write an expos
é
on Beljanski and publish it in the widely circulated political journal that Le Perlier worked for,
Minute
.

I met Monsieur Le Perlier at the CIRIS picnic I was invited to attend by Sylvie and Monique Beljanski (CIRIS stands for the
Center of Scientific Innovations, Research, and Information
).
They had asked me to come to France earlier that year in 2003 at the ACAM (American College of Advancement in Medicine) convention where I had learned about Dr. Beljanski’s work.
The picnic, held in La Rochelle, France, on September 5, 2003, was attended by several hundred people, but I was there to interview prior cancer victims who had used Beljanski’s products and who no longer suffered from cancer. I wanted to find out for myself how effective they really were.

At the time of my arrival in La Rochelle there were 3,522 officially recorded members of CIRIS plus another approximately two thousand formerly ill people who frequently attended meetings but did not pay dues. Almost all of these official and non-official attendees should have been dead from oncological or other degenerative illnesses one, two, or three decades before. Instead, many hundreds of them were present at the CIRIS picnic, and all in all, I interviewed three dozen former cancer patients. Each gave me written permission to use what they revealed about themselves.

The CIRIS members had paid my travel expenses and met me with smiling faces and open arms. The members’ goal was to convince me that the message they wanted delivered in book form had the potential to save millions of people from a variety of serious degenerative diseases. I had been told that Le Perlier’s story was especially important because he had information about President Fran
ç
ois Mitterrand, France’s president from 1981 through 1995, who had allegedly taken Beljanski’s formulas for his prostate cancer.

I wondered what had happened to Le Perlier that transformed him from a highly conservative medical skeptic to a true believer of holistic methods of health care. Cheating death is a powerful motivator for change, however, and that is exactly what happened to Le Perlier. It turns out, he saved his own life by using Dr. Beljanski’s products. I needed to know the full story.

The Personal Story of Journalist Jean-Paul Le Perlier

It is often said that truth is stranger than fiction, and that is most definitely the case with Jean-Paul Le Perlier. His story is so utterly fantastic that I must relate his narrative to you, transcribed from a tape recorder, most of it word for word:

“My best friend, who has rendered me enormous service and for whom I can refuse nothing, just happened to be the executive vice president of the French subsidiary of a major international manufacturer of chemotherapeutic agents,” began the famous French journalist. “My friend represents the interests of pharmaceuticals throughout Europe and the United States of America, including the Pharmaceutical Research and Manufacturers of America (the powerful lobby otherwise known to some as Big Pharma).

“During our visit together in the spring of 1992,” Le Perlier continued, “my friend advised that his drug company’s product sales were being adversely affected by a particular molecular biologist he referred to as ‘fraudulent and a quack.’ Knowing that I am a journalist, my friend asked me to do him a favor and undertake a journalistic investigation—write a special exposé on this ‘scoundrel’ whom he identified as ‘Mirko Beljanski, Ph.D.’

“And,” Le Perlier added with emphasis, “this vice president for the international drug company’s subsidiary told me, ‘It’s thought by some people that Beljanski’s products are curing cancer. Of course, this cannot be true because for decades pharmaceutical companies have attempted to do the same thing, but they have obviously failed. There is no cure, but numbers of medical consumers think this Beljanski faker has produced some kind of treatment to correct not only cancer but also AIDS. Certainly that thinking is nonsense when everyone knows that drugs, cytotoxic agents (substances that are toxic to cells), and other chemotherapies manufactured by my industry remain unsuccessful. If the pharmaceutical companies cannot cure cancer, then no one and nothing can do it.’”

Le Perlier made it clear that his friend was adamant: “‘Moreover, the simultaneous treatment of cancer and AIDS is obvious quackery,’ continued my friend, ‘since any knowledgeable person recognizes that a single set of products can’t be used for two dissimilar illnesses. With cancer coming from the body’s interior and AIDS contracted from its exterior, it’s absolutely impossible to conceive that one therapy would be useful for both. Beljanski must be a charlatan because with this scoundrel lecturing publicly, his is a ridicule of France’s scientific works. We in French drug manufacturing cannot put up with that snake-oil salesman’s offensive nostrum-peddling.’

“Consequently,” Le Perlier continued, speaking for himself now, “the drug company executive called upon me to warn people away from giving credence to research coming from this maverick professor. It was not difficult for me to see the advantages of producing an exposé article or even a series of articles. I figured it to be an easy assignment to accomplish.

“Since I am a journalist, and it was my responsibility to fill a full newspaper page of copy in the broadly-circulated French weekly political gazette,
Minute
, I could offer space for an exposé of Dr. Beljanski along with his so-called cancer- and AIDS-curing botanicals. Whether in politics or in health, I see my job as defending the interests of consumers,” Le Perlier stated firmly. “Incidentally,
Minute
with its political issues has now on September 7, 2003, gone out of print and is no longer published. When I brought this article assignment to my editors, however, they agreed that I should quickly move on the story.

“The editors’ joint decision was to have me
not
directly interview Beljanski; rather, my work must be dedicated to interviewing patients and to writing the story of only a few cancer victims who were using his treatments,” Le Perlier advised. “The editors’ intent was to have me speak to at least twenty-five of the patients and select two or three whose health I judged were being severely hurt by Beljanski. I expected to keep in touch with these unfortunates all the way through to their deaths, so that in follow-up articles my newspaper would be free from any possible lawsuits that evolved from publication of our ongoing expos
é
.

“My deadline to produce the first article was in two weeks. Consequently, I quickly sought out doctors and nurses who could put me in contact with cancer patients using Beljanski’s supplements,” continued Le Perlier. “I wanted to speak with any person who had negative statements to offer about them; only, I couldn’t find any. After fourteen days of interviewing, there were no contrary reports; the product users were happy and thriving. I failed to meet my deadline, and it became necessary for me to pull a previously written piece out of inventory and run that less-relevant article at the end of two weeks. Although I wanted badly to blast Beljanski, I had nothing to write that would condemn his practices or his products.

“I interviewed more Beljanski product-users for another two weeks, and the lack of disgruntled customers left me thwarted and feeling frustrated. Still, because of the promise I had made to my drug industry friend, the Beljanski investigation for me went on for several months more. Not one person during the entire time had anything negative to say about Dr. Beljanski’s discoveries. My published articles continued to contain nothing about that annoying molecular biologist,” Le Perlier said, smirking at the memory.

“Even so, my
Minute
page of copy had to be filled, and enthusiasm for the story died among my editors. Upon the newspaper’s managing editor expressing disappointment with the absence of any Beljanski expos
é
, I renewed my search for that scientist’s skullduggery by devoting about fifteen non-productive hours each week to the investigation for the balance of 1992,” Le Perlier told me.

Drugstore Owners Sue Beljanski

“Early the next year news came to me that a lawsuit brought by pharmacists on behalf of the Republic of France was ongoing against Dr. Beljanski in the southern city of Saint-Etienne. Plaintiffs’ attorneys claimed that the molecular biologist was using drugs illegally, and the sales of legitimate drugs were being adversely affected,” Le Perlier went on. “For a full week I attended the state trial of
Pharmacies of the French Republic versus Beljanski.